Literature DB >> 17729035

Multiple paths to loss of anergy and gain of autoimmunity.

Frank J Conrad1, Jeffrey S Rice, John C Cambier.   

Abstract

B cells and autoimmunity: cells of the immune system have the capacity to recognize/neutralize a myriad array of disease-causing pathogens, while simultaneously minimizing damage to self tissue. Obvious breakdowns in this ability to distinguish between self and non-self are evident in multiple forms of autoimmune disease, where B and T cells mount damaging attacks on cells and organs. B cells may directly damage tissue by producing pathogenic antibodies that bind self antigen, fix complement or form immune complexes. Recent evidence also suggests B cells indirectly induce autoimmunity by concentrating low avidity self antigen through the B cell receptor and presenting self-peptides to autoreactive T cells. B cells may also initiate autoimmunity when provided sufficient help from autoreactive T cells that have escaped deletion in the thymus. Here, we will review the role of anergy in maintenance of tolerance and how alterations in the normal balance of positive and negative signals may contribute to the development of autoimmune disease in mouse models and humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17729035     DOI: 10.1080/08916930701464723

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  12 in total

Review 1.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

Review 2.  Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

Authors:  Patrice Hemon; Yves Renaudineau; Marjolaine Debant; Nelig Le Goux; Sreya Mukherjee; Wesley Brooks; Olivier Mignen
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

3.  Differential STIM1 expression in T and B cell subsets suggests a role in determining antigen receptor signal amplitude.

Authors:  Yuval Yarkoni; John C Cambier
Journal:  Mol Immunol       Date:  2011-06-12       Impact factor: 4.407

4.  VISA is required for B cell expression of TLR7.

Authors:  Liang-Guo Xu; Lei Jin; Bi-Cheng Zhang; Linda J Akerlund; Hong-Bing Shu; John C Cambier
Journal:  J Immunol       Date:  2011-11-21       Impact factor: 5.422

5.  CD21lo B Cells Could Be a Potential Predictor of Immune-Related Adverse Events in Renal Cell Carcinoma.

Authors:  Kenichi Nishimura; Tatsuya Konishi; Toshiki Ochi; Ryuta Watanabe; Terutaka Noda; Tetsuya Fukumoto; Noriyoshi Miura; Yuki Miyauchi; Tadahiko Kikugawa; Katsuto Takenaka; Takashi Saika
Journal:  J Pers Med       Date:  2022-05-28

Review 6.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

7.  Protein kinase Cδ promotes transitional B cell-negative selection and limits proximal B cell receptor signaling to enforce tolerance.

Authors:  Andre Limnander; Julie Zikherman; Tannia Lau; Michael Leitges; Arthur Weiss; Jeroen P Roose
Journal:  Mol Cell Biol       Date:  2014-02-10       Impact factor: 4.272

Review 8.  Immunology of tissue homeostasis, ovarian cancer growth and regression, and long lasting cancer immune prophylaxis - review of literature.

Authors:  Antonin Bukovsky
Journal:  Histol Histopathol       Date:  2020-09-08       Impact factor: 2.303

9.  The role of B cells in systemic sclerosis.

Authors:  Marina D Kraaij; Jacob M van Laar
Journal:  Biologics       Date:  2008-09

10.  Tracking Differential Gene Expression in MRL/MpJ Versus C57BL/6 Anergic B Cells: Molecular Markers of Autoimmunity.

Authors:  Amy G Clark; Katherine M Mackin; Mary H Foster
Journal:  Biomark Insights       Date:  2008-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.